Amendments to the Regulations in terms of paragraph (d) of the Definition of “Scientific or Technological Research and Development” in Section 11D(1) of the Act on Additional Criteria for Multisource Pharmaceutical Products
Separate
Showing 1–3 of 3 published on 17 May 2024 · Departmental separate · National Treasury
3 gazettesPrevious publication day: ‹ 10 MayNext publication day: 30 May ›
Amendments to the Regulations in terms of paragraph (d) of the Definition of “Scientific or Technological Research and Development” in Section 11D(1) of the Act on Additional Criteria for Multisource Pharmaceutical Products
Amendments to the Regulations on Domestic Reverse Charge relating to Valuable Metal, issued in terms of section 74(2) of the Act
Amendments to the Regulations in terms of paragraph (e) of the Definition of “Scientific or Technological Research and Development” in Section 11D(1) of the Act on Criteria for clinical trials in respect of deduction for scientific or technological research and Development